The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market. This is very significant since most of the insider trades have been sales for the past year. On March 4, ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

With the initial Covid-19 vaccine rollout well underway, Moderna CEO Stéphane Bancel and his team are already planning for future Covid-19 vaccination campaigns. In a panel hosted by Pepperdine ...

Stéphane Bancel, Moderna’s founding chief executive, has sold his six-level Beacon Hill townhouse after owning in the ...

Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine ...

Moderna is working on a stronger tool to fight the COVID-19 pandemic. However, officials say it will take time. The drugmaker says research is underway toward a one-dose, yearly booster to battle the ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...

Moderna said on Monday that its combination vaccine that targets COVID-19 and the flu was more effective than their current separate vaccines for both viruses, according to new late-stage clinical ...